glutathione increase after treating with platinum drugs

glutathione increase after treating with platinum drugs Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Platinum drugs and taxanes: can

Name: glutathione increase after treating with platinum drugs Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Platinum drugs and taxanes: can
Brand: creatorsinfotech.com
SKU: 61728050298
Price: 29.63 USD
Availability: InStock
Rating: 4.0738 (7 reviews)

Platinum drugs and taxanes: can we overcome resistance? Cell Death Discovery Role of Glutathione in Cancer: From Mechanisms to Therapies Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Frontiers Glutathione Peroxidase 4 as a Therapeutic Target for Anti Colorectal Cancer Drug Tolerant Persister Cells Glutathione Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation PMC

SKU: 61728050298 · From creatorsinfotech.com

4.1

USD29.63 USD51.63

Pay in 4 interest-free payments of $7.41 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 13 - Oct 18

Description

Mosa, T.A

This study revealed a decrease in nitrogen metabolism, glycine and serine metabolism, gluconeogenesis, the oxidation of branched-chain fatty acids, and phytanic acid peroxisomal oxidation, phenylalanine-tyrosine metabolism, and tyrosine metabolism, indicating mitochondrial damage

Bacterial L-forms have relatively low ROS levels because mutations reduce ROS production via the respiratory chain

The chambers were placed side by side and filled with water to a depth of 5 cm

The specific activities were 10.2 U/mg with DTNB, 2.2 U/mg with Trx (coupled to insulin reduction), 7.2 U/mg with GSSG, and 9.9 U/mg in a Grx assay coupled to HED